Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Ankylosing Spondylitis

In brief

This is the first study of oral tofacitinib in adults with active ankylosing spondylitis. It is designed to obtain information on the efficacy and safety of 3 different doses of tofacitinib.

Key facts

Study ID
NCT01786668
Run by
Pfizer
People needed
208
Starts
2013-04-01
Expected to finish
2015-03-01
Last updated by the study team
2016-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.